Detalles de la búsqueda
1.
Replacing LNT: The Integrated LNT-Hormesis Model.
Dose Response
; 18(2): 1559325820913788, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32313523
2.
Reviving the acid phosphatase test for prostate cancer.
Oncology (Williston Park)
; 21(8): 1003-10, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17715699
3.
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapy.
J Oncol
; 20102010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20847945
4.
Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.
Urology
; 71(1): 146-50, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18242384
5.
Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features.
Cancer
; 110(3): 551-5, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577217
6.
Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
Urology
; 69(2): 334-7, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17320673
7.
Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase.
Cancer
; 97(4): 979-83, 2003 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12569596
Resultados
1 -
7
de 7
1
Próxima >
>>